Pharma Journalist -

Eli Lilly and Company and Incyte announced the U.S. Food and Drug Administration (FDA) has approved OLUMIANT (baricitinib) for the treatment of COVID-19 in hospitalized adults requiring…
Read More...

Neuvivo, a biopharmaceutical company dedicated to delivering an effective, safe ALS treatment to patients, announced that it has initiated cGMP manufacturing of NP001 for the treatment…
Read More...

Sound Pharmaceuticals, Inc. (SPI) is pleased to announce that is has received a $1.1M supplement to its $3.1M National Center for Advancing Translational Sciences (NCATS) Award,…
Read More...

SAE Media Group reports: The 2nd Annual Oligonucleotide Therapeutics & Delivery Conference is set to return in September 2022 with a key focus on advancements in extra-hepatic…
Read More...

Assessing device development and regulation for advanced innovation SAE Media Group’s 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA…
Read More...

Eiger Biopharmaceuticals Inc. and AnGes Inc. announced that the companies entered into an agreement for the regulatory approval, marketing, and distribution of Zokinvy (lonafarnib) for…
Read More...

MOMA Therapeutics, a biopharmaceutical company discovering the next generation of precision medicines by targeting molecular machines that underlie human disease, announced the…
Read More...

Thermo Fisher Scientific today launched a new collection of qPCR biopharma offerings to help accelerate drug development to meet a growing demand for novel biologics. The QualTrak…
Read More...

Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven, the maker of…
Read More...

Hitachi High-Tech Corporation has entered into a strategic partnership (the Partnership) with Invivoscribe, Inc. ("Invivoscribe"), a global provider of blood cancer testing kits and…
Read More...